TK1 and mastocytoma: The most important finding in this study was that when sera from dogs with mammary tumors, melanomas, and mastocytomas were analyzed with the two TK1 assays, we observed that only 10 out of 55 dogs showed increased TK1 activity levels compared to healthy dogs.